Express Scripts (ESRX) 55.45 0.00

EXPRESS SCRPTS HLDG
(ESRX) 55.45 0.00

Last Trade:	52.53	Day Range:	52.33 - 53.48
Trade Time:	08:05PM	52wk Range:	34.47 - 59.60
Prev. Close:	52.53	Market Cap:	42.31B
Open:	53.29	Div Yield:	0
Volume:	5705353	PE:	210
EPS:	2.47

The Latest On ESRX

UPDATE: Citigroup Cuts PT to $60 on Express Scripts on Outlook Update 5/17/12 10:04am

Oppenheimer Maintains Outperform Rating, $63 PT for Express Scripts 5/11/12 6:26pm

US Stock Futures Down; JPMorgan Shares Drop In Pre-Market Trading 5/11/12 6:34am

Stocks To Watch For May 11 5/11/12 3:44am

Earnings Expectations for the Week of May 7 (DIS, M, CSCO) 5/6/12 8:44am

CVS Earnings Climb 8.8% as Customers Switch Pharmacies 5/2/12 9:44am

Express Scripts Medco Heath Acquisition Faces Antitrust Concerns 4/11/12 9:06am

UPDATE: Jefferies Raises PT to $68 on Express Scripts 4/4/12 10:14am

Decoding Wall St.: Express Scripts and Medco Merger is No Joke 4/4/12 7:43am

UPDATE: Oppenheimer Provides a Company Update on Express Scripts 4/3/12 11:35am

Pharma benefits merger OK'd 4/2/12 6:36pm

Benzinga's M&A Chatter for Monday April 2, 2012 4/2/12 6:01pm

UPDATE: Citigroup Cuts PT to $60 on Express Scripts on Outlook Update 5/17/12

Oppenheimer Maintains Outperform Rating, $63 PT for Express Scripts 5/11/12

US Stock Futures Down; JPMorgan Shares Drop In Pre-Market Trading 5/11/12

Stocks To Watch For May 11 5/11/12

Earnings Expectations for the Week of May 7 (DIS, M, CSCO) 5/6/12

CVS Earnings Climb 8.8% as Customers Switch Pharmacies 5/2/12

Express Scripts Medco Heath Acquisition Faces Antitrust Concerns 4/11/12

UPDATE: Jefferies Raises PT to $68 on Express Scripts 4/4/12

Decoding Wall St.: Express Scripts and Medco Merger is No Joke 4/4/12

UPDATE: Oppenheimer Provides a Company Update on Express Scripts 4/3/12

Pharma benefits merger OK'd 4/2/12

Benzinga's M&A Chatter for Monday April 2, 2012 4/2/12

Stocks To Watch For May 11 5/11/12

Earnings Expectations for the Week of May 7 (DIS, M, CSCO) 5/6/12

Decoding Wall St.: Express Scripts and Medco Merger is No Joke 4/4/12

Pharma benefits merger OK'd 4/2/12

Benzinga's M&A Chatter for Monday April 2, 2012 4/2/12

Express Scripts Jumps On Medco Health Merger OK 4/2/12

Stocks Search For Direction; Express Scripts Surges 4/2/12

Morning Social Media Outlook for Monday April 2 (AVP, ESRX, D, GEO) 4/2/12

Benzinga's M&A Chatter for Wednesday March 7, 2012 3/8/12

Benzinga's M&A Chatter for Tuesday February 28, 2012 2/28/12

Benzinga's M&A Chatter for Monday February 6, 2012 2/6/12

3 Reasons Why The Stock Market Should Close After The Super Bowl 2/6/12

UPDATE: Citigroup Cuts PT to $60 on Express Scripts on Outlook Update 5/17/12

Oppenheimer Maintains Outperform Rating, $63 PT for Express Scripts 5/11/12

UPDATE: Jefferies Raises PT to $68 on Express Scripts 4/4/12

UPDATE: Oppenheimer Provides a Company Update on Express Scripts 4/3/12

Express Scripts Acquires Medco 4/2/12

Morning Social Media Outlook for Monday April 2 (AVP, ESRX, D, GEO) 4/2/12

UPDATE: Bank of America Raises Express Scripts' PT 3/29/12

Walgreen's Earnings Slide Amid Warm Weather, Ending Express Scripts Contract 3/27/12

UPDATE: Deutsche Bank Raises PT to $65 on Express Scripts 3/5/12

Oppenheimer Maintains Express Scripts Outperform Rating 2/23/12

Deutsche Bank Reiterates Buy, $66 PT on Medco 2/21/12

Trade ESRX
NOW!

Partner Headlines

2 Solid Dividends...And Bargains to Boot 5/31/12

Healthways Retained at Neutral - Analyst Blog 5/30/12

The Range Is Tightening in Express Scripts 5/25/12

Hedge Funds' Top 10 Stocks: For This They Get Two-and-Twenty? 5/23/12

SXC And Catalyst Catch Fire In Express Scripts Shadow 5/18/12

Why Did I Break Up With Him? Walgreens Probably Wants Ex-BF Express Scripts Back 5/18/12

Time to WAG the Dog 5/18/12

Express Scripts Is Approaching its 50 Day Moving Average 5/16/12

Some Big Cap 20 Stocks In Buy Area Despite Correction 5/14/12

CVS Reiterated at Neutral - Analyst Blog 5/14/12

Trading Idea: Key levels for Express Scripts 5/14/12

8 Stocks Ripping Higher on Big Volume 5/11/12

Press Releases

Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 5/17/12 Newswire

Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications 5/11/12 Newswire

Express Scripts Reports First Quarter Results 5/10/12 Newswire

InvestorsObserver releases comments on Disney, Boeing, Express Scripts, Kohls and Dolby Laboratories 5/7/12 Newswire

Express Scripts to Present at Bank of America Merrill Lynch Conference 5/4/12 Newswire

Waste Adds $2.1 Billion to Workers' Compensation Pharmacy Costs, Express Scripts Reports 4/17/12 Newswire

Express Scripts Launches ScreenRx(SM), Industry's First Solution Combining Early Detection and Tailored Interventions to Address Nation's $317 Billion Problem of Medication Nonadherence 4/16/12 Newswire

Notice of Redemption and Withdrawal of Class of Securities from Listing on the NYSE 4/6/12 Newswire

Express Scripts Announces First Quarter 2012 Earnings Conference Call 4/5/12 Newswire

Fitch Rates Express Scripts Holdings' IDRs 'BBB'; Removes Negative Watch & Assigns Negative Outlook 4/3/12 Business Wire

Express Scripts and Medco Health Solutions Complete Merger; Will Address National Mandate for More Affordable, Higher Quality Healthcare 4/2/12 Newswire

Critical Alerts for Visa, Express Scripts, Baker Hughes, Yelp, and 3D Systems by Seven Summits Research 3/22/12 Newswire

Get the latest ESRX stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for EXPRESS SCRPTS HLDG stock price.

EXPRESS SCRPTS HLDG by YCharts

Express Scripts (ESRX) 55.45 0.00

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ESRX

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social